Wilson's disease in Taiwan

Acta Neurologica Taiwanica

Volumn 17, Issue 2, 2008, Pages 75-81

  Chu, Nai Shin ^a,b   Huang, Chin Chang ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Cerebral white matter degeneration; Evoked potentials; Hepatolenticular degeneration; Taiwan; Wilson's disease

Indexed keywords

COPPER; PENICILLAMINE;

CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; ELECTROPHYSIOLOGY; ENDEMIC DISEASE; EVOKED RESPONSE; EVOKED VISUAL RESPONSE; HEPATITIS B; HUMAN; MEDICAL RESEARCH; PROGNOSIS; REVIEW; TAIWAN; UNITED STATES; WHITE MATTER; WILSON DISEASE;

BRAIN; HEPATITIS B; HEPATOLENTICULAR DEGENERATION; HUMANS; TAIWAN;

EID: 47149099599     PISSN: 10196099     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Wilson SAK. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain 1912;34:295-509.
2. Cumings JN. The copper and iron content of brain and liver in the normal and in hepatolenticular degeneration. Brain 1948;71:410-5.
3. Walshe JM. Penicillamine, a new oral therapy for Wilson's disease. Am J Med 1956;21:487-95.
4. Wong KC, Wu LT. History of Chinese Medicine, 2nd ed, Shanghai, China: National Quarantine Service, 1936.
5. Woods AH, Pendleton L. Fourteen simultaneous cases of an acute degenerative striatal disease. Arch Neurol Psychiatry 1925;13:549-68.
6. Cheng YL. Hepatolenticular degeneration (pseudo-sclerosis, progressive lenticular degeneration and torsion spasm). Chin Med J 1932;46:347-69.
7. Chang YC, Chin CC, Tsou HW. Clinical observation on twenty-five cases of hepatolenticular degeneration. Chin J Neurol Psychiatry 1957;3:45-59.
8. Feng YK. Wilson's disease. Report of ten cases. Chin Med J 1957;75:631-55.
9. Xu XH, Yang BX, Feng YK. Wilson's disease (hepatolenticular degeneration). Clinical analysis of 80 cases. Chin Med J 1981;94:673-8.
10. Cheng ST, Lee TC. Two cases of Wilson's disease. J Clin Pediat 1959;4:126-9. (in Chinese with an English abstract)
11. Tu JB. A genetic, biochemical and clinical study of Wilson's disease among Chinese in Taiwan. Acta Paediatr Sin 1963;4:81-104.
12. Tu JB, Blackwell RQ, Hou TY. Tissue copper levels in Chinese patients with Wilson's disease. Neurology 1963; 13:155-9.
13. Tu JB, Hung TP, Lin TY, et al. Study of Wilson's disease in Taiwan. J Philipp Med Assoc 1963;39:739-42.
14. Tu JB, Blackwell RQ, Cooper WC, et al. Studies of pyridoxal-penicillamine antagonism in the human. Biochem Pharmacol 1964;13:1527-35.
15. Tu JB, Blackwell RQ, Watten RH. Copper balance studies during the treatment of patients with Wilson's disease. Metabolism 1965;14:653-66.
16. Tu JB, Cooper WC, Blackwell RQ, et al. Treatment of hepatolenticular degeneration (Wilson's disease) in the asymptomatic stage. Neurology 1965;15:402-8.
17. Tu JB, Blackwell RQ. Studies on levels of penicillamine-induced cupriuresis in heterozygotes of Wilson's disease. Metabolism 1967;16:507-13.
18. Tu JB, Blackwell RQ, Fresh JW, et al. Diagnosis and treatment studies of patients in asymptomatic stage of Wilson's disease. Birth Defect 1968;4:114.
19. Leu ML, Strickland GT, Wang CC, et al. Skin pigmentation in Wilson's disease. JAMA 1970;211:1542-3.
20. Leu ML, Strickland GT, Gutman RA. Renal function in Wilson's disease: response to penicillamine therapy. Am J Med Sci 1970;260:381-98.
21. Yeh SJ, Leu ML, Strickland GT. Tissue copper, zinc, and manganese levels in Wilson's disease: studies with the use of neutron activation analysis. J Lab Clin Med 1971;77:438-44.
22. Leu ML, Strickland GT. Renal function in heterozygotes for Wilson's disease. Am J Med Sci 1972;263:19-26.
23. Strickland GT, Frommer D, Leu ML, et al. Wilson's disease in the United Kingdom and Taiwan. Q J Med 1973;42:619-38.
24. Strickland GT, Leu ML. Wilson's disease. Clinical and laboratory maniestations in 40 patients. Medicine (Baltimore) 1975;54:113-37.
25. Leu ML, Strickland GT. Renal tubular acidosis in Wilson's disease: characteristics, mechanisms and implications. J Formos Med Assoc 1977;76:829-42.
26. Chu NS, Yang SS, Cheng CL. Somatosensory evoked potentials: monitoring cerebral functions following liver transplantation. Clin Electroencephalogr 1985;16:192-4.
27. Chu NS. Sensory evoked potentials in Wilson's disease. Brain 1986;109:491-507.
28. Chen CL, Wang KL, Lee MC, et al. Liver transplantation for Wilson's disease. Report of the first successful liver transplant in Taiwan. Transplantation (Japan) 1987;22:178-84.
29. Chu NS, Yang SS. Brainstem auditory evoked potentials in different types of hepatic diseases. Electroencephalogr Clin Neurophysiol 1987;67:337-9.
30. Chu NS. Clinical, CT and evoked potential manifestations in Wilson's disease with cerebral white matter involvement. Clin Neurol Neurosurg 1989;91:45-51.
31. Chu NS. Motor evoked potentials in Wilson's disease: early and late motor responses. J Neurol Sci 1990;99:259-69.
32. Chu NS, Chu CC, Tu SC, et al. EEG spectral analysis and topographic mapping in Wilson's disease. J Neurol Sci 1991;106:1-9.
33. Soong YK, Huang HY, Huang CC, et al. Successful pregnancy after D-penicillamine therapy in a patient with Wilson's disease. J Formos Med Assoc 1991;90:693-6.
34. Huang CC, Chu NS. Wilson's disease: clinical analysis of 71 cases and comparison with previous Chinese series. J Formos Med Assoc 1992;91:502-7.
35. Huang CC, Chu NS. Wilson's disease: resolution of cerebral white matter lesions following long-term penicillamine therapy. J Formos Med Assoc 1992;91:627-9.
36. Chu NS, Hung TP. Geographic variations in Wilson's disease. J Neurol Sci 1993;117:1-7.
37. Chu NS. Blink reflex in Wilson's disease. J Formos Med Assoc 1994;93:56-60.
38. Huang CC, Chu NS. Psychosis and epileptic seizures in Wilson's disease with predominantly white matter lesions in the frontal lobe. Parkinsonism Relat Disord 1995;1:53-8.
39. Chu CC, Huang CC, Chu NS. Recurrent hypokalemic muscle weakness as an initial manifestation of Wilson's disease. Nephron 1996;73:477-9.
40. Huang CC, Chu NS. Wilson's disease: resolution of MRI lesions following long-term oral zinc therapy. Acta Neurol Scand 1996;93:215-8.
41. Chu EC, Chu NS, Huang CC. Autonomic involvement in Wilson's disease: a study of sympathetic skin response and RR interval variation. J Neurol Sci 1997;149:131-7.
42. Huang CC, Chu NS, Chen RS. Asymmetric dystonia with frontal white matter lesions in Wilson's disease. Eur J Neurol 1997;4:240-5.
43. Huang CC, Chu NS. Acute dystonia with thalamic and brainstem lesions after initial Penicillamine treatment in Wilson's disease. Eur Neurol 1998;39:32-7.
44. Yu JM, Chu EC, Chu NS, et al. Wilson's disease with hepatitis B infection: occurrence, clinical presentation, and prognosis. Acta Neurol Taiwan 1998;7:262-5.
45. Chu NS, Huang CC. Cerebral white matter involvement in Wilson's disease. Acta Neurol Taiwan 1999;8:217-22.
46. Wu JC, Huang CC, Jeng LB, et al. Correlation of neurological manifestations and MR images in a patient with Wilson's disease after liver transplantation. Acta Neurol Scand 2000;102:135-9.
47. Huang CC, Chu NS, Yen TC, et al. Dopamine transporter binding in Wilson's disease. Can J Neurol Sci 2003;30:163-7.
48. Chu NS, Huang CC. Face of the teddy bear in Wilson's disease: more than just one kind of beast in the midbrain. Acta Neurol Taiwan 2003;12:106-7.
49. Cumings JN. Trace metals in the brain and in Wilson's disease. J Clin Pathol 1968;21:1-7.
50. Starosta-Rubinstein S, Young AB, Kluin K, et al. Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging. Arch Neurol 1987;44:365-70.
51. Prayer L, Wimberger D, Kramer J, et al. Cranial MRI in Wilson's disease. Neuroradiology 1990;32:211-4.
52. King AD, Walshe JM, Kendall BE, et al. Cranial MR imaging in Wilson's disease. AJR Am J Roentgenol 1996;167:1579-84.
53. Wilkinson ML, Portmann B, Williams R. Wilson's disease and hepatocellular carcinoma: possible protective role of copper. Gut 1983;24:767-71.
54. Polio J, Enriquez RE, Chow A, et al. Hepatocellular carcinoma in Wilson's disease. Case report and review of the literature. J Clin Gastroenterol 1989;11:220-4.